Sitemap > Breaking Research > GenitoUrinary Tract Disorders
Displaying 651 - 700 of 759 results
- 2-Phenyl-4-piperazinylbenzimidazoles: Orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor.
- Long-term safety and effectiveness of sildenafil citrate in men with erectile dysfunction.
- The effect of chronic partial bladder outlet obstruction on corpus cavernosum smooth muscle and Rho-kinase in rabbits.
- Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Highly Potent and Selective Human beta3 Adrenergic Receptor Agonists with Good Oral Bioavailability. Part II.
- GABAergic mechanism mediated via D(1) receptors in the rat periaqueductal gray participates in the micturition reflex: an in vivo microdialysis study.
- Intraprostatic Botulinum Toxin A Injection Inhibits Cyclooxygenase-2 Expression and Suppresses Prostatic Pain on Capsaicin Induced Prostatitis Model in Rat.
- Anti-TNF-{alpha} treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial.
- 7-Aminopyrazolo[1,5-a]pyrimidines as Potent Multitargeted Receptor Tyrosine Kinase Inhibitors.
- Long-Term Safety and Efficacy of Tadalafil 5 mg Dosed Once Daily in Men with Erectile Dysfunction.
- An Excitatory Role for Peripheral EP3 Receptors In Bladder Afferent Function.
- AMTB, a TRPM8 Channel Blocker: Evidence in Rats for Activity in Overactive Bladder and Painful Bladder Syndrome.
- Effect of Sildenafil Citrate on the Male Sexual Experience Assessed with the Sexual Experience Questionnaire: A Multicenter, Double-Blind, Placebo-Controlled Trial with Open-Label Extension.
- Efficacy and Safety of Alprostadil Cream for the Treatment of Female Sexual Arousal Disorder: A Double-Blind, Placebo-Controlled Study in Chinese Population.
- A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome.
- Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study.
- Increased alpha1D adrenergic receptor activity and protein expression in the urinary bladder of aged rats.
- 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.
- Impacts of the quinazoline-based alpha1-antagonist, terazosin, and of the sulfonamide derivative, tamsulosin, on serum prostate-specific antigen and prostate volume.
- Is There a Synergistic Effect of Topical Oestrogens When Administered with Antimuscarinics in the Treatment of Symptomatic Detrusor Overactivity?
- 1-[1-hexyl-6-(methyloxy)-1H-indazol-3-yl]-2-methyl-1-propanone (HMIMP), a Potent and Highly Selective Small Molecule Blocker of the Large-Conductance Voltage-gated and Calcium-dependent K+ Channel.
- Pharmacological characterization of a novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum.
- The Translational Pharmacology Of A Novel, Potent And Selective Non-steroidal Progesterone Receptor Antagonist, PF-02367982.
- Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.
- Toll-like receptor 4-mediated growth of endometriosis by human heat-shock protein 70.
- Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome.
- Increased Expression of NKX3.1 in Benign Prostatic Hyperplasia.
- Sildenafil Citrate Improves Erectile Function and Lower Urinary Tract Symptoms Independent of Baseline Body Mass Index or LUTS Severity.
- The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis.
- Interleukin-4 Stimulates Proliferation of Endometriotic Stromal Cells.
- Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo.
- Investigation of the role of 5-HT(2) receptor subtypes in the control of the bladder and the urethra in the anaesthetized female rat.
- Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged > or =65 years.
- Comparative analysis of alpha-blocker utilization in combination with 5-alpha reductase inhibitors for enlarged prostate in a managed care setting among Medicare-aged men.
- Cost comparison of finasteride and dutasteride for enlarged prostate in a managed care setting among Medicare-aged men.
- Tamsulosin modified release and oral controlled absorption system in the management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
- Methyl (11aS)-1,2,3,5,11,11a-Hexahydro-3,3-dimethyl-1-oxo-6H-imidazo-[3',4':1,2]pyridin[3,4-b]indol-2-Substituted Acetates: Synthesis and Three-Dimensional Quantitative Structure-Activity Relationship Investigation as a Class of Novel Vasodilators.
- Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial.
- Erectile Dysfunction Among Men with Diabetes is Strongly Associated with Premature Ejaculation and Reduced Libido.
- The efficacy of venlafaxine in the treatment of women with stress urinary incontinence.
- A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder.
- A randomized, double-blind, placebo-controlled phase II dose-finding study of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder.
- Efficacy and Safety of Mirodenafil, A New Oral Phosphodiesterase Type 5 Inhibitor, for Treatment of Erectile Dysfunction.
- Effect of Vardenafil on Blood Pressure Profile of Patients With Erectile Dysfunction Concomitantly Treated With Doxazosin Gastrointestinal Therapeutic System for Benign Prostatic Hyperplasia.
- Effect of Tolterodine Extended Release With or Without Tamsulosin on Measures of Urgency and Patient Reported Outcomes in Men With Lower Urinary Tract Symptoms.
- Long-Term Treatment With Finasteride Results in a Clinically Significant Reduction in Total Prostate Volume Compared to Placebo Over the Full Range of Baseline Prostate Sizes in Men Enrolled in the MTOPS Trial.
- Design and optimization of potent, selective antagonists of Oxytocin.
- Effects of intrathecal injection of a hyperpolarization-activated channel (I(h)) inhibitor ZD7288 on bladder function in urethane-anesthetized rats.
- In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors.
- Efficacy of doxazosin in the treatment of acute urinary retention due to benign prostate hyperplasia.
- Efficacy and safety of oral SK3530 for the treatment of erectile dysfunction in Korean men: a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel group clinical trial.